annual EBITDA:
$17.04B+$8.47B(+98.88%)Summary
- As of today (April 12, 2025), LLY annual EBITDA is $17.04 billion, with the most recent change of +$8.47 billion (+98.88%) on December 31, 2024.
- During the last 3 years, LLY annual EBITDA has risen by +$9.00 billion (+111.86%).
- LLY annual EBITDA is now at all-time high.
Performance
LLY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$5.68B+$3.43B(+152.77%)Summary
- As of today (April 12, 2025), LLY quarterly EBITDA is $5.68 billion, with the most recent change of +$3.43 billion (+152.77%) on December 31, 2024.
- Over the past year, LLY quarterly EBITDA has stayed the same.
- LLY quarterly EBITDA is now at all-time high.
Performance
LLY quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$15.16B+$2.65B(+21.15%)Summary
- As of today (April 12, 2025), LLY TTM EBITDA is $15.16 billion, with the most recent change of +$2.65 billion (+21.15%) on December 31, 2024.
- Over the past year, LLY TTM EBITDA has stayed the same.
- LLY TTM EBITDA is now at all-time high.
Performance
LLY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LLY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +98.9% | 0.0% | 0.0% |
| 3 y3 years | +111.9% | +184.8% | +87.6% |
| 5 y5 years | +147.0% | +184.8% | +87.6% |
LLY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.9% | at high | +490.1% | at high | +87.6% |
| 5 y | 5-year | at high | +147.0% | at high | +490.1% | at high | +95.1% |
| alltime | all time | at high | >+9999.0% | at high | +291.0% | at high | +7554.0% |
Eli Lilly and Company EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $17.04B(+98.9%) | $5.68B(+152.8%) | $15.16B(+21.2%) |
| Sep 2024 | - | $2.25B(-45.4%) | $12.51B(+11.4%) |
| Jun 2024 | - | $4.12B(+32.1%) | $11.23B(+15.9%) |
| Mar 2024 | - | $3.12B(+2.7%) | $9.69B(+13.1%) |
| Dec 2023 | $8.57B(-1.1%) | $3.03B(+215.2%) | $8.57B(+5.9%) |
| Sep 2023 | - | $962.80M(-62.6%) | $8.09B(-11.5%) |
| Jun 2023 | - | $2.58B(+29.1%) | $9.14B(+13.0%) |
| Mar 2023 | - | $1.99B(-21.9%) | $8.08B(-6.7%) |
| Dec 2022 | $8.66B(+7.7%) | $2.56B(+27.1%) | $8.66B(+2.2%) |
| Sep 2022 | - | $2.01B(+32.1%) | $8.47B(+3.7%) |
| Jun 2022 | - | $1.52B(-40.9%) | $8.17B(-6.1%) |
| Mar 2022 | - | $2.57B(+8.8%) | $8.70B(+8.2%) |
| Dec 2021 | $8.04B(-9.8%) | $2.37B(+38.3%) | $8.04B(-6.5%) |
| Sep 2021 | - | $1.71B(-16.5%) | $8.60B(-2.0%) |
| Jun 2021 | - | $2.05B(+7.1%) | $8.78B(-0.1%) |
| Mar 2021 | - | $1.91B(-34.6%) | $8.78B(-1.5%) |
| Dec 2020 | $8.91B(+29.2%) | $2.93B(+55.2%) | $8.91B(+10.2%) |
| Sep 2020 | - | $1.89B(-8.3%) | $8.09B(+1.0%) |
| Jun 2020 | - | $2.06B(+0.5%) | $8.00B(+3.0%) |
| Mar 2020 | - | $2.05B(-2.6%) | $7.77B(+12.6%) |
| Dec 2019 | $6.90B(+24.7%) | $2.10B(+16.6%) | $6.90B(+12.5%) |
| Sep 2019 | - | $1.80B(-1.3%) | $6.13B(-0.3%) |
| Jun 2019 | - | $1.82B(+55.4%) | $6.15B(+26.6%) |
| Mar 2019 | - | $1.17B(-12.0%) | $4.86B(-12.2%) |
| Dec 2018 | $5.53B(+35.0%) | $1.33B(-26.6%) | $5.53B(+9.2%) |
| Sep 2018 | - | $1.82B(+242.8%) | $5.06B(+18.5%) |
| Jun 2018 | - | $530.20M(-71.3%) | $4.27B(-21.6%) |
| Mar 2018 | - | $1.85B(+113.5%) | $5.45B(+33.1%) |
| Dec 2017 | $4.10B(-19.0%) | $866.30M(-15.6%) | $4.10B(-9.3%) |
| Sep 2017 | - | $1.03B(-40.0%) | $4.52B(-7.8%) |
| Jun 2017 | - | $1.71B(+245.6%) | $4.90B(+7.6%) |
| Mar 2017 | - | $494.70M(-61.6%) | $4.55B(-9.9%) |
| Dec 2016 | $5.06B(+15.5%) | $1.29B(-8.7%) | $5.06B(+9.9%) |
| Sep 2016 | - | $1.41B(+3.6%) | $4.60B(-0.7%) |
| Jun 2016 | - | $1.36B(+36.7%) | $4.63B(+6.3%) |
| Mar 2016 | - | $995.70M(+19.6%) | $4.36B(-0.5%) |
| Dec 2015 | $4.38B(-3.3%) | $832.20M(-42.4%) | $4.38B(-1.3%) |
| Sep 2015 | - | $1.45B(+33.2%) | $4.44B(+10.2%) |
| Jun 2015 | - | $1.08B(+6.8%) | $4.03B(-5.6%) |
| Mar 2015 | - | $1.02B(+14.1%) | $4.27B(-5.8%) |
| Dec 2014 | $4.53B(-39.6%) | $890.40M(-14.1%) | $4.53B(-8.3%) |
| Sep 2014 | - | $1.04B(-21.8%) | $4.94B(-14.9%) |
| Jun 2014 | - | $1.32B(+3.7%) | $5.80B(-9.3%) |
| Mar 2014 | - | $1.28B(-1.8%) | $6.40B(-14.6%) |
| Dec 2013 | $7.50B(+6.3%) | $1.30B(-31.6%) | $7.50B(-1.3%) |
| Sep 2013 | - | $1.90B(-0.9%) | $7.59B(-4.9%) |
| Jun 2013 | - | $1.92B(-19.1%) | $7.98B(+4.3%) |
| Mar 2013 | - | $2.37B(+69.5%) | $7.65B(+8.6%) |
| Dec 2012 | $7.05B(+2.0%) | $1.40B(-38.9%) | $7.05B(-0.2%) |
| Sep 2012 | - | $2.29B(+44.0%) | $7.06B(+5.8%) |
| Jun 2012 | - | $1.59B(-10.0%) | $6.67B(-4.9%) |
| Mar 2012 | - | $1.77B(+25.2%) | $7.01B(+1.5%) |
| Dec 2011 | $6.91B(-14.1%) | $1.41B(-26.0%) | $6.91B(-5.2%) |
| Sep 2011 | - | $1.91B(-1.4%) | $7.29B(-2.1%) |
| Jun 2011 | - | $1.93B(+16.3%) | $7.45B(-2.6%) |
| Mar 2011 | - | $1.66B(-7.3%) | $7.64B(-4.9%) |
| Dec 2010 | $8.04B(+16.2%) | $1.79B(-13.2%) | $8.04B(+2.9%) |
| Sep 2010 | - | $2.06B(-3.1%) | $7.81B(+8.7%) |
| Jun 2010 | - | $2.13B(+3.6%) | $7.19B(+4.2%) |
| Mar 2010 | - | $2.05B(+31.4%) | $6.89B(-0.3%) |
| Dec 2009 | $6.92B(>+9900.0%) | $1.56B(+8.7%) | $6.92B(+190.8%) |
| Sep 2009 | - | $1.44B(-21.7%) | $2.38B(+129.9%) |
| Jun 2009 | - | $1.84B(-11.5%) | $1.03B(+42.3%) |
| Mar 2009 | - | $2.08B(-169.8%) | $727.00M(+1579.0%) |
| Dec 2008 | $43.30M(-99.3%) | -$2.98B(-3248.4%) | $43.30M(-99.0%) |
| Sep 2008 | - | $94.50M(-93.8%) | $4.50B(-23.5%) |
| Jun 2008 | - | $1.53B(+9.8%) | $5.88B(+0.3%) |
| Mar 2008 | - | $1.39B(-6.0%) | $5.87B(+0.3%) |
| Dec 2007 | $5.85B(+18.7%) | $1.48B(+0.5%) | $5.85B(+4.5%) |
| Sep 2007 | - | $1.48B(-2.6%) | $5.60B(+3.9%) |
| Jun 2007 | - | $1.52B(+10.0%) | $5.39B(+6.2%) |
| Mar 2007 | - | $1.38B(+11.9%) | $5.08B(+3.0%) |
| Dec 2006 | $4.93B(+12.6%) | $1.23B(-2.6%) | $4.93B(+0.5%) |
| Sep 2006 | - | $1.26B(+5.1%) | $4.90B(+3.1%) |
| Jun 2006 | - | $1.20B(-2.2%) | $4.76B(+3.4%) |
| Mar 2006 | - | $1.23B(+1.9%) | $4.60B(+5.1%) |
| Dec 2005 | $4.38B(+2.8%) | $1.21B(+8.0%) | $4.38B(+2.2%) |
| Sep 2005 | - | $1.12B(+6.8%) | $4.28B(+2.2%) |
| Jun 2005 | - | $1.05B(+4.2%) | $4.19B(-0.2%) |
| Mar 2005 | - | $1.00B(-9.6%) | $4.20B(-1.4%) |
| Dec 2004 | $4.26B | $1.11B(+8.3%) | $4.26B(+2.8%) |
| Sep 2004 | - | $1.03B(-2.7%) | $4.14B(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $1.06B(-0.6%) | $4.20B(+1.3%) |
| Mar 2004 | - | $1.06B(+6.6%) | $4.14B(+2.3%) |
| Dec 2003 | $4.05B(+6.0%) | $996.40M(-7.9%) | $4.05B(+0.1%) |
| Sep 2003 | - | $1.08B(+7.8%) | $4.05B(+1.4%) |
| Jun 2003 | - | $1.00B(+3.6%) | $3.99B(+2.1%) |
| Mar 2003 | - | $968.60M(-2.4%) | $3.91B(+2.3%) |
| Dec 2002 | $3.82B(-8.7%) | $992.40M(-3.2%) | $3.82B(+3.4%) |
| Sep 2002 | - | $1.03B(+11.3%) | $3.70B(+0.1%) |
| Jun 2002 | - | $920.90M(+4.4%) | $3.69B(-6.4%) |
| Mar 2002 | - | $882.30M(+1.7%) | $3.95B(-5.7%) |
| Dec 2001 | $4.18B(+4.7%) | $867.20M(-15.2%) | $4.18B(-3.1%) |
| Sep 2001 | - | $1.02B(-12.9%) | $4.32B(-2.6%) |
| Jun 2001 | - | $1.18B(+5.0%) | $4.43B(+5.4%) |
| Mar 2001 | - | $1.12B(+12.1%) | $4.20B(+5.2%) |
| Dec 2000 | $4.00B(+5.1%) | $999.00M(-12.2%) | $4.00B(-1.7%) |
| Sep 2000 | - | $1.14B(+20.2%) | $4.07B(+3.2%) |
| Jun 2000 | - | $946.80M(+3.8%) | $3.94B(+2.5%) |
| Mar 2000 | - | $911.80M(-14.7%) | $3.85B(+1.1%) |
| Dec 1999 | $3.80B(+14.7%) | $1.07B(+5.4%) | $3.80B(+6.0%) |
| Sep 1999 | - | $1.01B(+18.9%) | $3.59B(+3.9%) |
| Jun 1999 | - | $852.40M(-1.9%) | $3.45B(+3.4%) |
| Mar 1999 | - | $868.50M(+1.7%) | $3.34B(+0.8%) |
| Dec 1998 | $3.31B(+12.4%) | $854.30M(-2.8%) | $3.31B(+3.9%) |
| Sep 1998 | - | $878.60M(+18.8%) | $3.19B(+3.7%) |
| Jun 1998 | - | $739.50M(-12.2%) | $3.08B(+2.1%) |
| Mar 1998 | - | $842.50M(+15.5%) | $3.01B(+2.2%) |
| Dec 1997 | $2.95B(+13.9%) | $729.40M(-4.6%) | $2.95B(+1.9%) |
| Sep 1997 | - | $764.50M(+13.0%) | $2.89B(+3.3%) |
| Jun 1997 | - | $676.50M(-13.0%) | $2.80B(+3.7%) |
| Mar 1997 | - | $777.80M(+15.1%) | $2.70B(+4.5%) |
| Dec 1996 | $2.59B(+2.1%) | $675.70M(+0.4%) | $2.59B(+3.5%) |
| Sep 1996 | - | $673.10M(+16.7%) | $2.50B(+1.0%) |
| Jun 1996 | - | $577.00M(-12.8%) | $2.48B(-0.8%) |
| Mar 1996 | - | $662.00M(+12.5%) | $2.50B(-1.5%) |
| Dec 1995 | $2.54B(+13.8%) | $588.70M(-9.2%) | $2.54B(+13.9%) |
| Sep 1995 | - | $648.00M(+8.4%) | $2.23B(+5.9%) |
| Jun 1995 | - | $597.80M(-14.7%) | $2.10B(+6.2%) |
| Mar 1995 | - | $701.00M(+151.7%) | $1.98B(+10.2%) |
| Dec 1994 | $2.23B(+111.9%) | $278.50M(-46.8%) | $1.79B(+126.9%) |
| Sep 1994 | - | $523.50M(+10.2%) | $790.90M(+16.2%) |
| Jun 1994 | - | $475.10M(-8.2%) | $680.50M(+2.8%) |
| Mar 1994 | - | $517.80M(-171.4%) | $662.10M(+1.5%) |
| Dec 1993 | $1.05B(-31.0%) | -$725.50M(-275.6%) | $652.60M(-64.2%) |
| Sep 1993 | - | $413.10M(-9.5%) | $1.82B(+65.3%) |
| Jun 1993 | - | $456.70M(-10.2%) | $1.10B(+1.8%) |
| Mar 1993 | - | $508.30M(+14.1%) | $1.08B(-6.2%) |
| Dec 1992 | $1.52B(-26.3%) | $445.30M(-244.9%) | $1.16B(+1.1%) |
| Sep 1992 | - | -$307.40M(-170.3%) | $1.14B(-38.5%) |
| Jun 1992 | - | $437.50M(-24.6%) | $1.86B(+0.4%) |
| Mar 1992 | - | $580.10M(+33.9%) | $1.85B(+4.8%) |
| Dec 1991 | $2.07B(+15.7%) | $433.20M(+5.9%) | $1.77B(+2.8%) |
| Sep 1991 | - | $409.00M(-5.0%) | $1.72B(+2.5%) |
| Jun 1991 | - | $430.30M(-13.2%) | $1.68B(+4.5%) |
| Mar 1991 | - | $495.80M(+28.7%) | $1.61B(+4.3%) |
| Dec 1990 | $1.79B(+28.2%) | $385.30M(+5.2%) | $1.54B(+12.7%) |
| Sep 1990 | - | $366.40M(+2.5%) | $1.37B(+9.2%) |
| Jun 1990 | - | $357.60M(-16.9%) | $1.25B(+4.7%) |
| Mar 1990 | - | $430.10M(+103.5%) | $1.19B(-40.0%) |
| Dec 1989 | $1.39B(+11.5%) | $211.30M(-15.9%) | $1.99B(-1077.6%) |
| Sep 1989 | - | $251.20M(-16.5%) | -$203.40M(-141.9%) |
| Jun 1989 | - | $301.00M(-75.4%) | $486.00M(-59.5%) |
| Mar 1989 | - | $1.23B(-161.8%) | $1.20B(+14.6%) |
| Dec 1988 | $1.25B(+60.5%) | -$1.98B(-310.6%) | $1.05B(+78.0%) |
| Sep 1988 | - | $940.60M(-7.3%) | $588.10M(-2.8%) |
| Jun 1988 | - | $1.01B(-5.4%) | $605.20M(-0.5%) |
| Mar 1988 | - | $1.07B(-144.0%) | $608.10M(+2.2%) |
| Dec 1987 | $779.30M(-24.9%) | -$2.44B(-354.7%) | $595.00M(-48.0%) |
| Sep 1987 | - | $957.70M(-5.9%) | $1.14B(+6.9%) |
| Jun 1987 | - | $1.02B(-3.9%) | $1.07B(+14.9%) |
| Mar 1987 | - | $1.06B(-156.0%) | $931.00M(+8.2%) |
| Dec 1986 | $1.04B(+15.3%) | -$1.89B(-314.0%) | $860.30M(-19.0%) |
| Sep 1986 | - | $883.40M(+0.5%) | $1.06B(+9.9%) |
| Jun 1986 | - | $879.30M(-11.0%) | $966.30M(+14.5%) |
| Mar 1986 | - | $988.30M(-158.5%) | $843.80M(+10.4%) |
| Dec 1985 | $900.60M(+4.1%) | -$1.69B(-314.4%) | $764.30M(-11.8%) |
| Sep 1985 | - | $787.90M(+4.1%) | $866.50M(+9.5%) |
| Jun 1985 | - | $756.80M(-16.7%) | $791.20M(+4.3%) |
| Mar 1985 | - | $908.80M(-157.3%) | $758.30M(+1.9%) |
| Dec 1984 | $865.00M | -$1.59B(-322.7%) | $744.30M(-68.1%) |
| Sep 1984 | - | $712.60M(-1.6%) | $2.33B(+44.0%) |
| Jun 1984 | - | $723.90M(-19.1%) | $1.62B(+80.9%) |
| Mar 1984 | - | $894.80M | $894.80M |
FAQ
- What is Eli Lilly and Company annual EBITDA?
- What is the all time high annual EBITDA for Eli Lilly and Company?
- What is Eli Lilly and Company annual EBITDA year-on-year change?
- What is Eli Lilly and Company quarterly EBITDA?
- What is the all time high quarterly EBITDA for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly EBITDA year-on-year change?
- What is Eli Lilly and Company TTM EBITDA?
- What is the all time high TTM EBITDA for Eli Lilly and Company?
- What is Eli Lilly and Company TTM EBITDA year-on-year change?
What is Eli Lilly and Company annual EBITDA?
The current annual EBITDA of LLY is $17.04B
What is the all time high annual EBITDA for Eli Lilly and Company?
Eli Lilly and Company all-time high annual EBITDA is $17.04B
What is Eli Lilly and Company annual EBITDA year-on-year change?
Over the past year, LLY annual EBITDA has changed by +$8.47B (+98.88%)
What is Eli Lilly and Company quarterly EBITDA?
The current quarterly EBITDA of LLY is $5.68B
What is the all time high quarterly EBITDA for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly EBITDA is $5.68B
What is Eli Lilly and Company quarterly EBITDA year-on-year change?
Over the past year, LLY quarterly EBITDA has changed by $0.00 (0.00%)
What is Eli Lilly and Company TTM EBITDA?
The current TTM EBITDA of LLY is $15.16B
What is the all time high TTM EBITDA for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM EBITDA is $15.16B
What is Eli Lilly and Company TTM EBITDA year-on-year change?
Over the past year, LLY TTM EBITDA has changed by $0.00 (0.00%)